betaxolol hydrochloride has been researched along with h 89 in 1 studies
| Studies (betaxolol hydrochloride) | Trials (betaxolol hydrochloride) | Recent Studies (post-2010) (betaxolol hydrochloride) | Studies (h 89) | Trials (h 89) | Recent Studies (post-2010) (h 89) |
|---|---|---|---|---|---|
| 13 | 0 | 3 | 1,619 | 0 | 409 |
| Protein | Taxonomy | betaxolol hydrochloride (IC50) | h 89 (IC50) |
|---|---|---|---|
| Rho-associated protein kinase 2 | Homo sapiens (human) | 1.9504 | |
| Ribosomal protein S6 kinase alpha-5 | Homo sapiens (human) | 0.12 | |
| cAMP-dependent protein kinase catalytic subunit alpha | Bos taurus (cattle) | 0.073 | |
| cAMP-dependent protein kinase catalytic subunit alpha | Mus musculus (house mouse) | 0.381 | |
| cAMP-dependent protein kinase catalytic subunit alpha | Homo sapiens (human) | 0.6365 | |
| cAMP-dependent protein kinase catalytic subunit gamma | Homo sapiens (human) | 0.6365 | |
| cAMP-dependent protein kinase catalytic subunit beta | Homo sapiens (human) | 0.6365 | |
| Ribosomal protein S6 kinase beta-1 | Homo sapiens (human) | 0.08 | |
| RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | 1.9886 | |
| RAC-beta serine/threonine-protein kinase | Homo sapiens (human) | 0.5417 | |
| Rho-associated protein kinase 2 | Rattus norvegicus (Norway rat) | 0.27 | |
| RAC-gamma serine/threonine-protein kinase | Homo sapiens (human) | 0.3207 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
1 other study(ies) available for betaxolol hydrochloride and h 89
| Article | Year |
|---|---|
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |